Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas
- 10 August 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 26 (12) , 2239-2255
Abstract
Human gliomas are classified using isocitrate dehydrogenase (IDH) status as a prognosticator; however, the influence of genetic differences and treatment effects on ensuing immunity remains unclear. In this study, we used sequential single-cell transcriptomics on 144,678 and spectral cytometry on over two million immune cells encompassing 48 human gliomas to decipher their immune landscape. We identified 22 distinct immune cell types that contribute to glioma immunity. Specifically, brain-resident microglia (MG) were reduced with a concomitant increase in CD8+ T lymphocytes during glioma recurrence independent of IDH status. In contrast, IDH-wild-type-associated patterns, such as an abundance of antigen-presenting cell-like MG and cytotoxic CD8+ T cells, were observed. Beyond elucidating the differences in IDH, relapse, and treatment-associated immunity, we discovered novel inflammatory MG subpopulations expressing granulysin, a cytotoxic peptide, which is otherwise expressed in lymphocytes only. Furthermore, we provide a robust genomic framework for defining macrophage polarization beyond M1/M2 paradigm and reference signatures of glioma-specific tumor immune microenvironment (termed Glio-TIME-36) for deconvoluting transcriptomic datasets. This study provides advanced optics of the human pan-glioma immune contexture as a valuable guide for translational and clinical applications.Keywords
All Related Versions
Funding Information
- The University of Texas (UT) MD Anderson Cancer Center
- Marnie Rose Foundation
- UT MDACC start-up research fund
- CPRIT Single Core (RP180684)
This publication has 55 references indexed in Scilit:
- Glioma progression is shaped by genetic evolution and microenvironment interactionsCell, 2022
- Microglia and monocytes in inflammatory CNS disease: integrating phenotype and functionActa Neuropathologica, 2021
- Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysisCell, 2021
- Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading LeukocytesCell, 2020
- Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune CellsCell, 2020
- Current State of Immunotherapy for Treatment of GlioblastomaCurrent Treatment Options in Oncology, 2019
- Profiling Tumor Infiltrating Immune Cells with CIBERSORT2018
- The Microenvironmental Landscape of Brain TumorsCancer Cell, 2017
- Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain MalignanciesCell Reports, 2016
- Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local MicroenvironmentCell, 2014